Navigation Links
Elbit Imaging Ltd. Announces that InSightec Announces that the FDA has Approved Exablate System for Treatment in the USA
Date:10/7/2015

TEL AVIV, Israel, October 7, 2015 /PRNewswire/ --

Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today that it was informed by InSightec Ltd. ("InSightec"), that the United States Food and Drug Administration (FDA) has approved InSightec's next generation Exablate system to treat symptomatic uterine fibroids and changed the labeling to allow consideration for women who desire to maintain fertility. The updated labeling specifies that ablation of uterine fibroid tissue can now be considered for women with symptomatic uterine fibroids, who desire to retain fertility and spare their uterus.

InSightec estimates that such change in labeling provides younger women suffering from symptomatic fibroids access to a new, non-invasive treatment option that is safe, effective and keeps their uterus intact without compromising their existing ability to get pregnant. The approval is based on accumulated, documented clinical data on 118 patients' pregnancies post Exablate MRgFUS treatments.

FDA approval of INSIGHTEC's next generation Exablate system offers treating physicians a more advanced technology.

The Company holds approximately 82.7% of the share capital of Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M) (on a fully diluted basis) which, in turn, holds approximately 29.6% of the share capital in InSightec (on a fully diluted basis).

About Elbit Imaging Ltd. 

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii) Hotels - hotels operation and management. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Residential projects - initiation, construction and sale of residential units or plots designated for residential located primarily in India.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2014, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements. 

For Further Information: 

Company Contact

Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com


'/>"/>
SOURCE Elbit Imaging Ltd.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Elbit Imaging Announces Its Subsidiary, Plaza Centers, Has Announced on an Acquisition of Loan to Control Liberec Plaza in the Czech Republic
2. Elbit Imaging Announces Receipt of a Court Resolution That Schedules the Dates for Written Response and Hearing of the Interim Injunction Motion for Temporary Remedies
3. Elbit Imaging Ltd. Appoints its Chief Financial Officer, Doron Moshe, as Acting CEO
4. Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited
5. Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
6. Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
7. Elbit Imaging Announces the Results of the Companys Unsecured Financial Creditors Meeting Approving the General Terms of Agreement to be Entered Into With Bank Hapoalim
8. Elbit Imaging Ltd. Announces Results of its General Meeting
9. Elbit Imaging Ltd. Announces (1) Courts Resolution Regarding the Results of Creditors Meeting and (2) Results of Extraordinary General Meeting
10. Elbit Imaging Ltd. Announces First Quarter Results For 2013
11. Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... ... July 07, 2020 , ... With projects ranging from nourishing ... 33 nonprofits who received the latest ISA Foundation grants will make ... foundation awarded grants totaling $838,527 to the U.S.-based 501(c)(3) nonprofit organizations. , ...
(Date:7/4/2020)... ... July 03, 2020 , ... By Heidi Jean Doerfert , ... into our homes for cover, Assuaged, Inc. is going full speed ahead. ... the globe this year to get their feet wet in marketing, social media content, ...
(Date:7/2/2020)... ... July 02, 2020 , ... Realty ONE Group International, one ... on its live agent Town Halls, furthering its commitment to its real estate ... special guests and Realty ONE Group leadership discussing social, mental, physical and financial ...
Breaking Medicine Technology:
(Date:7/10/2020)... ... July 10, 2020 , ... Traliant, an innovator in online sexual harassment ... managers on the Family and Medical Leave Act (FMLA), and the new Families First ... provisions related to COVID-19. , For more information, please visit: FMLA ...
(Date:7/7/2020)... ... July 07, 2020 , ... Mediaplanet recently launched an awareness initiative to ... thrust this field into the spotlight and, as a result, the Bureau of ... In partnership with South University — which offers a Master’s in Public ...
(Date:7/7/2020)... ... 07, 2020 , ... Great Point Partners (“GPP”) today announced that the Spine ... Rick Katz as Vice President of Business Development. , "After a comprehensive search ... leadership role for the organization," said Adam Elberg, chairman of the Spine & Sport ...
(Date:7/4/2020)... ... July 03, 2020 , ... The latest SARS-CoV-2 news, ... hub— Future Lab: COVID-19 R&D . , Future Lab is an ... within specific scientific niches. Since their launch four years ago, the Future Lab ...
(Date:7/4/2020)... S.C. (PRWEB) , ... July 03, 2020 , ... ... older adults living with memory impairment, has announced the Best Memory Care Facilities ... location, access to experts, facility features and amenities. , According to the ...
Breaking Medicine News(10 mins):